Mandatory Notification of Trade
Please refer to the attached form of notification of transaction by primary insider.
This notification has been submitted pursuant to the Securities Trading Act § 5-12 and MAR Article 19 no. 3.
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Elanders AB: Quarterly Report January – March 202419.4.2024 10:00:00 CEST | Press release
First quarter 2024 Net sales amounted to MSEK 3,268 (3,589), which corresponded to an organic net sales reduction of nine percent, excluding acquisitions and discontinued operations, and using unchanged exchange rates. The reduction is primarily a result of a weaker market and lower freight rates and volumes in the Group’s Air & Sea freight forwarding operations.Adjusted EBITA amounted to MSEK 180 (217), which equaled an adjusted EBITA margin of 5.5 (6.0) percent.During the period, one-off items of MSEK -26 (-67) where charged to operating result. These mainly referred to acquisition costs.Adjusted net result amounted to MSEK 32 (77), corresponding to SEK 0.89 (2.16) per share.Operating cash flow adjusted for purchase prices for acquisitions increased to MSEK 641 (512). Operating cash flow including acquisitions amounted to MSEK 121 (512).Cash conversion increased to 137 (122) percent, excluding purchase prices for acquisitions.In February 2024, Elanders acquired almost 90 percent of t
Elanders AB: Delårsrapport januari – mars 202419.4.2024 10:00:00 CEST | Pressemelding
Första kvartalet 2024 Omsättningen uppgick till 3 268 (3 589) Mkr. Det motsvarade en organisk omsättningsminskning om nio procent, om förvärv samt nedlagd verksamhet exkluderas och oförändrade valutakurser används. Denna minskning var främst ett resultat av en svagare marknad samt lägre fraktpriser och volymer inom förmedlingen av Air & Sea-transporter.Justerad EBITA uppgick till 180 (217) Mkr, vilket motsvarade en justerad EBITA-marginal om 5,5 (6,0) procent.Rörelseresultatet belastades med engångsposter om -26 (-67) Mkr som huvudsakligen avsåg förvärvskostnader.Justerat nettoresultat uppgick till 32 (77) Mkr, motsvarande 0,89 (2,16) kronor per aktie.Operativt kassaflöde justerat för köpeskillingar för förvärv ökade till 641 (512) Mkr. Operativt kassaflöde inklusive förvärv uppgick till 121 (512) Mkr.Cash conversion ökade till 137 (122) procent, om köpeskillingar för förvärv exkluderas.I februari 2024 förvärvade Elanders nästan 90 procent av aktierna i det engelska bolaget Bishopsgate
HSBC Continental Europe: Post Stabilisation Notice19.4.2024 09:30:00 CEST | Press release
PARIS, April 19, 2024 (GLOBE NEWSWIRE) -- NBN Co Limited Post Stabilisation Notice HSBC (contact: syndexecution@noexternalmail.hsbc.com) hereby gives notice that no stabilisation was undertaken by the Stabilisation Manager(s) named below in relation to the offer of the following securities. Issuer:NBN Co LimitedGuarantor (if any):naAggregate nominal amount:EUR 700,000,000 / EUR 600,000,000Description:3.5% due 22nd March 2030 / 3.75% due 22nd March 2034Offer price:99.660 / 99.926 Stabilising Manager:HSBC Continental Europe This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of t
NEXEN Tire hosts ‘2024 Purple Summit Korea’19.4.2024 09:00:00 CEST | Press release
Carried out sixth hospitality program inviting 60 global partners and executives from around the world SEOUL, South Korea, April 19, 2024 (GLOBE NEWSWIRE) -- NEXEN Tire, a leading global tire manufacturer, today announced that it hosted the 2024 Purple Summit Korea hospitality event, which took place in Korea for the first time from April 16 to 19. The event featured 60 global partners and executives from all over the world, as well as NEXEN Tire representatives. Since 2016, NEXEN Tire has hosted the Purple Summit, an integrated hospitality and marketing program, that aims to foster and strengthen relationships while also increasing the company's global market presence. Throughout the summit, attendees visited the company’s cutting-edge tire plant located in Changnyeong, as well as The NEXEN UniverCity, NEXEN Tire’s central R&D hub. Not only that, but the tire maker invited KLPGA players from the NEXEN-St. Nine Masters event to play golf with guests and tour Busan, Korea’s second large
Fujifilm Healthcare Europe launches lifelike ESD training simulator EndoGel19.4.2024 09:00:00 CEST | Press release
RATINGEN, Germany, April 19, 2024 (GLOBE NEWSWIRE) -- FUJIFILM Healthcare Europe GmbH is pleased to announce the launch of EndoGel, a training model designed for performing Endoscopic Submucosal Dissection (ESD) and Peroral Endoscopic Myotomy (POEM) procedures. This innovative simulator, available in two versions - EndoGel for ESD and EndoGel for ESD/POEM - represents a significant advance in endoscopic training. This simulator aims to improve the skills of endoscopy professionals across Europe and ultimately improve patient outcomes. EndoGel simulates the texture of human tissue involved in ESD and POEM procedures, providing clinicians with a life-like simulation experience. With this unique and innovative training model, endoscopy professionals can benefit from the ability to - practice marking and injecting, - performing circumferential incisions, - performing submucosal dissection, myotomy and clipping. EndoGel is compatible with a wide range of medical devices used in ESD and POEM